Skip to content

Gentamicin 120 Ug, Streptomycin 30 Ug Sensi-disc Susceptibility Tests

by Becton Dickinson Microbiology Systems

510(k) K943407

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK943407 Date27 Oct 1994ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

Full name
Gentamicin 120 Ug, Streptomycin 30 Ug Sensi-Disc Suspectibility Tests
510(k) Number
FDA Product Code
JTN
Device Class
Class II
Regulation
21 CFR Part 866.1620
Advisory Committee
Microbiology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 21 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

This device is a susceptibility test disc containing gentamicin 120 ug and streptomycin 30 ug, used for antimicrobial susceptibility testing in microbiology laboratories. It is designed to determine the sensitivity of microorganisms to these antibiotics via the disc diffusion method.

The device is supplied as a sterile, single-use test disc and is intended for use in clinical laboratory settings. It has received FDA 510(k) clearance under product code JTN and regulation number 866.1620, and is classified as a Class II medical device.

Other devices from Becton Dickinson Microbiology Systems

See all devices from Becton Dickinson Microbiology Systems →

Questions

AI-generated answers, 21 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What antibiotics and concentrations are on this susceptibility test disc?

    The disc combines gentamicin at 120 µg and streptomycin at 30 µg. These fixed amounts allow the disc diffusion method to assess whether a microorganism is sensitive, intermediate, or resistant to each agent based on zone‑of‑inhibition measurements.

  • Is the disc supplied sterile and intended for single use?

    Yes, the product is provided as a sterile, single‑use test disc. Sterility ensures no contaminating organisms affect the diffusion results, and single‑use eliminates cross‑contamination between specimens, which is essential for reliable susceptibility data.

  • In what laboratory setting should this disc be used?

    The disc is designed for clinical microbiology laboratories that perform antimicrobial susceptibility testing. It is used with standard agar plates and the disc diffusion technique to evaluate the susceptibility of bacterial isolates to gentamicin and streptomycin.

  • How is this device classified and what regulatory clearance does it have?

    It is classified as a Class II medical device and has received FDA 510(k) clearance (product code JTN, regulation 866.1620). The clearance indicates it is substantially equivalent to a legally marketed predicate device for the same intended use.